CPC A61K 31/4433 (2013.01) [A61K 31/496 (2013.01); A61K 39/39533 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01)] | 4 Claims |
1. A method of treating cutaneous T cell lymphoma (CTCL), said method comprising administering to a subject in need thereof an effective amount of a Chemokine Receptor 2 (CCR2) antagonist, wherein said CCR2 inhibitor is selected from the group consisting of:
![]() or a pharmaceutically acceptable salt thereof.
|